単純ヘルペス感染症(Herpes Simplex Infections)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Herpes Simplex Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Herpes Simplex Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Herpes Simplex Infections 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Herpes Simplex Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Herpes Simplex Infections 33
Apr 27, 2015: NanoViricides Discusses the Strong Effectiveness of Its Anti-Herpes Drug Candidates in a Lethal Animal Model of Dermal Herpes Infection 33
Apr 20, 2015: NanoViricides Reports that Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms in an Animal Model 33
Apr 10, 2015: Admedus has high hopes for Herpes vaccine as dosing commences 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
CRA Holdings, Inc. 39
Clinical Trial Overview of CRA Holdings, Inc. 39
Maruho Co., Ltd. 40
Clinical Trial Overview of Maruho Co., Ltd. 40
Astellas Pharma Inc. 41
Clinical Trial Overview of Astellas Pharma Inc. 41
Santo Holding AG 42
Clinical Trial Overview of Santo Holding AG 42
Benchmark Research 43
Clinical Trial Overview of Benchmark Research 43
Agenus, Inc. 44
Clinical Trial Overview of Agenus, Inc. 44
Hammersmith Medicines Research Ltd. 45
Clinical Trial Overview of Hammersmith Medicines Research Ltd. 45
Genocea Biosciences, Inc. 46
Clinical Trial Overview of Genocea Biosciences, Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
University of Washington 47
Clinical Trial Overview of University of Washington 47
The National Institute of Allergy and Infectious Diseases 48
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 48
National Center for Research Resources 49
Clinical Trial Overview of National Center for Research Resources 49
University of Pittsburgh 50
Clinical Trial Overview of University of Pittsburgh 50
French National Agency for Research on AIDS and Viral Hepatitis 51
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 51
National Eye Institute 52
Clinical Trial Overview of National Eye Institute 52
U.S. Department of Veterans Affairs 53
Clinical Trial Overview of U.S. Department of Veterans Affairs 53
University Health Network 54
Clinical Trial Overview of University Health Network 54
Assistance Publique Hopitaux De Marseille 55
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 55
Blood Systems Research Institute 56
Clinical Trial Overview of Blood Systems Research Institute 56
Five Key Clinical Profiles 57
Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 87